Aim: To search for the key factors of autoimmune pancreatitis (AIP) in China and to improve the early identification of AIP in order to avoid misdiagnosing it as pancreatic carcinoma. Methods: Clinical, imaging, laboratory, and pathological data about AIP were collected and analyzed from 1996 to 2011 in The Chinese People's Liberation Army General Hospital. Results: A total of 33 patients (male 29, female 4) aged 35-76 years (52.3 ± 9.3 years) meeting the International Consensus Diagnostic Criteria for type 1 (n = 32) or type 2 (n = 1) AIP were included. With improved understanding of AIP, the misdiagnosis rate and unnecessary laparotomy rate was decreased from 95.7% (22/23) and 91.3% (21/23) before 2006, to 20.0% (2/10) (p = 0.001) and 0.0% (p = 0.001) respectively after 2006. The major symptoms were jaundice in (24/33, 72.7%) and abdominal pain (12/33, 36.4%). Half of the patients had other accompanied autoimmune disorders. Laboratory tests showed an elevated level of serum IgG in 9 out of 11 patients (81.8%) and an increased eosinophil count in 16 out of 33 patients (48.5%). The serum IgG4 levels were twice the upper limit of the normal value. CT scan showed a low-contrast margin characterized by a capsule-like rim in 24 of 32 patients (75.0%). Pathologic examinations showed fibrosis and infiltration of massive lymphocytes and plasma cells in the pancreas. Prednisone was given to the patients and proved to be quite effective for all of them (12/12, 100%). Conclusion: Type 1 AIP shows a sex predilection compared with type 2 AIP in China. In order to diagnose AIP exactly, a comprehensive strategy, especially including imaging and pathological examination, should be used. With growing awareness, fewer AIP patients with this diagnosis would be misdiagnosed and incorrectly treated.

Journal Section:
Original Paper
Keywords:
Pancreatitis, Pancreatic carcinoma, Autoimmune pancreatitis, Autoimmunity
1.
Sarles H, Sarles JC, Muratore R, Guien C: Chronic inflammatory sclerosis of the pancreas - an autonomous pancreatic diseases? Am J Dig Dis 1961;6:688-698.
[PubMed]
https://doi.org/10.1007/BF02232341
2.
Yoshida K, Toki F, Takeuchi T, Watanabe SI, Shiratori K, Hayashi N: Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 1995;40:1561-1568.
[PubMed]
https://doi.org/10.1007/BF02285209
3.
Chari ST, Smyrk TC, Levy MJ, Topazian MD, Takahashi N, Zhang LZ, Clain JE, Pearson RK, Petersen BT, Vege SS, Farnell MB: Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroentero Hepatol 2006;4:1010-1016.
[PubMed]
https://doi.org/10.1016/j.cgh.2006.05.017
4.
Shimosegawa T, Chari ST, Frulloni L, Kamisawa T, Kawa S, Mino-Kenudson M, Kim MH, Klöppel G, Lerch MM, Löhr M, Notohara K, Okazaki K, Schneider A, Zhang L: International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas 2011;40:352-358.
[PubMed]
https://doi.org/10.1097/MPA.0b013e3182142fd2
5.
Kim KP, Kim MH, Song MH, Lee SS, Seo DW, Lee SK: Autoimmune chronic pancreatitis. Am J Gastroenterol 2004;99:1605-1616.
[PubMed]
https://doi.org/10.1111/j.1572-0241.2004.30336.x
6.
Wu XN: Chronic autoimmune pancreatitis. Chin J Gastro Hepa 2003;12:518-519.
7.
Kamisawa T, Wakabayashi T, Sawabu N: Autoimmune pancreatitis in young patients. Clin Gastroenterol 2006;40:847-850.
[PubMed]
https://doi.org/10.1097/01.mcg.0000225604.10611.61
8.
Ohara H, Nakazawa T, Ando T, Joh T: Systemic extrapancreatic lesions associated with autoimmune pancreatitis. J Gastroenterol 2007;42:15-21.
[PubMed]
https://doi.org/10.1007/s00535-007-2045-9
9.
Aparisi L, Farre A, Gomez-Cambronero L, Martinez J, De las Heras G, Corts J, Navarro S, Mora J, Lopez-Hoyos M, Sabater L, Ferrandez A, Bautista D, Perez-Mateo M, Mery S, Sastre J: Antibodies to carbonic anhydrase and IgG4 levels in idiopathic chronic pancreatitis: relevance for diagnosis of autoimmune pancreatitis. Gut 2005;54:703-709.
https://doi.org/10.1136/gut.2004.047142
10.
Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, Fukushima M, Nikaido T, Nakayama K, Usuda N, Kiyosawa K: High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001;344:732-738.
[PubMed]
https://doi.org/10.1056/NEJM200103083441005
11.
Okazaki K, Uchida K, Ohana M, Nakase H, Uose S, Inai M, Matsushima Y, Katamura K, Ohmori K, Chiba T: Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response. Gastroenterology 2000;118:573-581.
[PubMed]
https://doi.org/10.1016/S0016-5085(00)70264-2
12.
Hart PA, Kamisawa T, Brugge WR, Chung JB, Culver EL, Czakó L, Frulloni L, Go VL, Gress TM, Kim MH, Kawa S, Lee KT, Lerch MM, Liao WC, Löhr M, Okazaki K, Ryu JK, Schleinitz N, Shimizu K, Shimosegawa T, Soetikno R, Webster G, Yadav D, Zen Y, Chari ST: Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut 2012, E-pub ahead of print.
[PubMed]
https://doi.org/10.1136/gutjnl-2012-303617
13.
Kamisawa T, Tabata T, Hara S, Kuruma S, Chiba K, Kanno A, Masamune A, Shimosegawa T: Recent advances in autoimmune pancreatitis. Front Physiol 2012;3:374.
[PubMed]
https://doi.org/10.3389/fphys.2012.00374
14.
Shimizu Y, Yamamoto M, Naishiro Y, Sudoh G, Ishigami K, Yajima H, Tabeya T, Matsui M, Suzuki C, Takahashi H, Seki N, Himi T, Yamashita K, Noguchi H, Hasegawa T, Suzuki Y, Honda S, Abe T, Imai K, Shinomura Y: Necessity of early intervention for IgG4-related disease - delayed treatment induces fibrosis progression. Rheumatology (Oxford) 2013;52:679-683.
[PubMed]
https://doi.org/10.1093/rheumatology/kes358
15.
Horiuchi A, Kawa S, Hamano H, Hayama M, Ota H, Kiyosawa K: ERCP features in 27 patients with autoimmune pancreatitis. Gastrointest Endosc 2002;55:494-499.
[PubMed]
16.
Pearson RK, Longnecker DS, Chari ST, Smyrk TC, Okazaki K, Frulloni L, Cavallini G: Controversies in clinical pancreatology: autoimmune pancreatitis: does it exist? Pancreas 2003;27:1-13.
[PubMed]
https://doi.org/10.1097/00006676-200307000-00001
17.
Park SJ, Kim MH, Moon SH, Han JH, Park do H, Lee SS, Seo DW, Lee SK: Clinical characteristics, recurrence features, and treatment outcomes of 55 patients with autoimmune pancreatitis (in Korean). Korean J Gastroenterol 2008;52:230-246.
[PubMed]
18.
Kamisawa T, Okamoto A: Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease. J Gastroenterol 2006;41:613-625.
[PubMed]
https://doi.org/10.1007/s00535-006-1862-6
19.
Shiokawa M, Kodama Y, Yoshimura K, Kawanami C, Mimura J, Yamashita Y, Asada M, Kikuyama M, Okabe Y, Inokuma T, Ohana M, Kokuryu H, Takeda K, Tsuji Y, Minami R, Sakuma Y, Kuriyama K, Ota Y, Tanabe W, Maruno T, Kurita A, Sawai Y, Uza N, Watanabe T, Haga H, Chiba T: Risk of cancer in patients with autoimmune pancreatitis. Am J Gastroenterol 2013;108:610-617.
[PubMed]
https://doi.org/10.1038/ajg.2012.465
20.
Chang WI, Kim BJ, Lee JK, Kang P, Lee KH, Lee KT, Rhee JC, Jang KT, Choi SH, Choi DW, Choi D, Lim JH: The clinical and radiological characteristics of focal mass-forming autoimmune pancreatitis comparison with chronic pancreatitis and pancreatic cancer. Pancreas 2009;38:401-408.
[PubMed]
https://doi.org/10.1097/MPA.0b013e31818d92c0
21.
Fujimori N, Ito T, Igarashi H, Oono T, Nakamura T, Niina Y, Hijioka M, Lee L, Uchida M, Takayanagi R: Retroperitoneal fibrosis associated with immunoglobulin G4-related disease. World J Gastroenterol 2013;19:35-41.
[PubMed]
https://doi.org/10.3748/wjg.v19.i1.35
22.
Kamisawa T, Tu Y, Egawa N, Tsuruta K, Okamoto A, Kodama M, Kamata N: Can MRCP replace ERCP for the diagnosis of autoimmune pancreatitis? Abdom Imaging 2009;34:381-384.
[PubMed]
https://doi.org/10.1007/s00261-008-9401-y
23.
Kubota K, Kato S, Akiyama T, Yoneda M, Fujita K, Ogawa M, Inamori M, Kobayashi N, Saito S, Kakuta Y, Ohshiro H, Nakajima A: Differentiating sclerosing cholangitis caused by autoimmune pancreatitis and primary sclerosing cholangitis according to endoscopic duodenal papillary features. Gastrointest Endoc 2008;68:1204-1208.
[PubMed]
https://doi.org/10.1016/j.gie.2008.08.013
24.
Kamisawa T, Tu YY, Egawa N, Tsuruta K, Okamoto A: A new diagnostic endoscopic tool for autoimmune pancreatitis. Gastrointest Endoc 2008;68:358-361.
[PubMed]
https://doi.org/10.1016/j.gie.2008.02.018
25.
Kamisawa T, Egawa N, Nakajima H, Tsuruta K, Okamoto A, Hayashi Y, Funata N: Gastrointestinal findings in patients with autoimmune pancreatitis. Endoscopy 2005;37:1127-1130.
[PubMed]
https://doi.org/10.1055/s-2005-870369
© 2013 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2013
You do not currently have access to this content.